[Intrinsic sympathomimetic activity with beta-receptor blockers. Significance for differential therapy (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000378:metabolism / Q000627:therapeutic use*; D000818:Animals; D003327:Coronary Disease / Q000188:drug therapy*; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy; D008173:Lung Diseases, Obstructive / Q000188:drug therapy; D009200:Myocardial Contraction / Q000187:drug effects; D012893:Sleep Wake Disorders / Q000139:chemically induced; D013566:Sympathomimetics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D013566:Sympathomimetics
Intrinsische sympathomimetische Aktivität bei Beta-Rezeptorenblockern. Differentialtherapeutische Bedeutung.